THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$189.28
-0.21 (-0.11%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
10d
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: THC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: THC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$224.29
Based on 2.6% avg growth
INTRINSIC VALUE TODAY
$139.26
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $189.28, which is considered fair relative to its 30-day fair value range of $193.40 to $203.18. The stock's valuation (Forward PE: 11.6) is in line with its historical norms (12.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, THC is showing sideways momentum. The price is currently testing key support at $185.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: THC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $237.67 (+25.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, THC is showing sideways momentum. The price is currently testing key support at $185.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: THC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $237.67 (+25.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$193.40 -
$203.18
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding THC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.4% below Wall St target ($237.67)
Fair Price Analysis
30-Day Fair Range
$193.40 -
$203.18
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$185.00
Resistance Level
$201.28
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
11.62
Wall Street Target
$237.67
(+25.4%)
Revenue Growth (YoY)
3.2%
Earnings Growth (YoY)
-21.1%
Profit Margin
6.5%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
11.6 vs 12.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$187.22
(-1%)
2-Year Target
$184.97
(-2%)
3-Year Target
$182.75
(-4%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
$190.30
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 1.2%)
$377.11
(+99%)
Base:
(SPY PE: 11.6, Growth: 1.2%)
$196.50
(+4%)
Bear:
(PE: 9.9, Growth: 1.2%)
$167.03
(-12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 12.88 | Current EPS (TTM): $14.72
Bull Case
$231.03
(+22%)
Analyst growth 10.8%, PE expands to 14.2
Base Case
$210.02
(+11%)
Market implied 10.8%, PE stable at 12.9
Bear Case
$128.91
(-32%)
Severe decline -20.0%, PE contracts to 11.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.6 to 12.1
Stabilization Target:
$197.32
(+4.1%)
PE Expansion Potential:
+4.1%
Last updated: January 30, 2026 7:46 PM ET
Data refreshes hourly during market hours. Next update: 8:46 PM
Data refreshes hourly during market hours. Next update: 8:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Saumya Sutaria
SELL
78762 shares
2025-09-10
Jonathan L. Jackson
BUY
2025-09-03
Christopher S Lynch
SELL
8 shares
2025-08-28
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$489 | 63 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$140 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$17 | 52 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$28 | 62 BUY |
|
ACHC
Acadia Healthcare Compan… |
STRONG BUY
14 analysts |
$19 | 55 HOLD |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
